MeSH D007964 - leukocytosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Barr Pharmaceuticals | Hydroxyurea | Hydroxyurea | 1998-07-30 | |||
| CHEPLAPHARM Arzneimittel | Hydroxyurea | Droxia | 1982-01-01 | |||
| Endo | Hydroxyurea | Hydroxyurea | 1999-02-24 | |||
| Leading Pharma | Hydroxyurea | Hydroxyurea | 2020-04-08 | |||
| Nova Laboratories | Hydroxyurea | Xromi | 2024-04-04 | |||
| Qilu Pharmaceuticals | Hydroxyurea | Hydroxyurea | 2024-03-06 | |||
| Roxane Laboratories | Hydroxyurea | Hydroxyurea | 1995-08-18 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/3
Phase 2
0%0/0
Phase 3
100%1/1
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use